Code | 2081D | ||||||||||
MA number | 44/0219/19-S | ||||||||||
Product Form: | cps dur 30x37,5 mg (fľ.HDPE) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Mylan Ireland Limited, Ireland | ||||||||||
Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 48 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 24.07.2019 |
PIL: |
|
SPC: |
|
Safety feature | Yes |
Data update: | 09.05.2024 |